Macleods Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is POMALIDOMIDE, with a corresponding US DMF Number 41092.
Remarkably, this DMF maintains an Active status since its submission on April 08, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 02, 2026, and payment made on December 26, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II